ClinicalTrials.gg
Not yet recruitingNCT06392542Updated Jul 28, 2026

Whole Selves User Testing and Feasibility Study

An interventional study of Whole Selves in Alcohol Use, Unspecified, Relationship, Social and Depression, Anxiety, sponsored by Boston University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-28.

Primary conditionDepressionRegistry: Alcohol DrinkingReclassifiedWhy we changed it
Registry
Alcohol Drinking — the first condition term the registry derived for this study.
ClinicalTrials.gg
Depression
Why
  1. Alcohol Drinking is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Depression.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Boston University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
107
Allocation
Not applicable
Ages
18 Years to 30 Years
Sex
All
01

Study summary

Whole Selves is a novel print and online intervention using motivational interviewing principles and personalized feedback to address young adults' alcohol use and romantic relationship functioning. In this study, the investigators will conduct user testing interviews (online and in-person) with 10 young adults to obtain feedback on the Whole Selves intervention prototype, thereby improving its usability, relevance, and user engagement. The investigators will then conduct a single-arm feasibility study of Whole Selves with 107 young adults in order to (1) assess the intervention's acceptability and potential mechanisms and (2) assess feasibility and parameters for a future randomized trial.

02

Conditions studied

  • Alcohol Use, Unspecified
  • Relationship, Social
  • Depression, Anxiety

Browse trials for

Keywords

  • Interactive online alcohol education
  • Interactive online relationship education
  • Whole Selves intervention
  • Supportive romantic relationships
03

In context

Depression Reclassified

8,577 studies on the registry are indexed under Depression; 1,720 are open to participants now.

This study's planned enrollment of 107 is above the median of 81 across 7,063 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Boston University is the lead sponsor of 270 studies on the registry; 36 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 24 (77%) have results posted.

Compared within Depression, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Alcohol Drinking. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Able to read and write in English
  • Residency in the United States
  • Currently in a romantic relationship that began at least six weeks prior to enrollment

Exclusion criteria

Exclusion Criteria:

  • Referral source has generated other suspicious responses
  • Submitted within 48 hours of other responses with similar or identical content
  • Blank or nonsense response to at least one write-in question
  • Email address has pattern common in inauthentic responses (e.g., full name followed by a 3- or 4-digit number, last name followed by first name, or full name that appears unrelated to participant's stated name)
  • Reported nonstandard demographic information
  • Provided an email address with a domain other than gmail.com
  • Via Zoom, displaying a photo ID associated with the reported location (school/employer IDs acceptable)
  • Via Zoom, displaying a physical item associated with the reported location, such as a transit pass, library card, or university paraphernalia
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
107 participants (estimated)

Study arms

  • Experimental
    Whole Selves

    Participants assigned to this arm will receive the Whole Selves intervention and complete assessment surveys at baseline, 30 days, and 90 days.

    Behavioral: Whole Selves

Interventions

  • BehavioralWhole Selves

    Whole Selves is a brief online self-guided intervention addressing transgender/nonbinary young adults' experiences with alcohol use and romantic relationships. The intervention is delivered in a single session of approximately 40 minutes. Whole Selves employs principles of technology-adapted motivational interviewing (e.g., eliciting and strengthening participants' internal reasons for behavior change through interactive activities) as well as personalized feedback on participants' self-reported alcohol use and romantic relationship experiences. The intervention incorporates text and video narratives from transgender/nonbinary people sharing their own experiences with alcohol use and romantic relationships. Content will be tailored based on participants' current alcohol use and romantic relationship experiences.

06

What researchers measure

Primary outcomes

  1. Alcoholic drinks per week

    Average (mean) number of alcoholic drinks per week based on 14-day timeline followback, i.e., retrospective self-report of drinks per day.

    Time frame: Baseline, 30 days, 90 days

  2. Depression symptoms

    Self-report of depression symptoms in the prior 30 days, as measured by the Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 is a 9-item questionnaire with each item scored from 0 to 3. Scores can range from 0 to 27 (scores of 5-9 are classified as mild depression; 10-14 as moderate depression; 15-19 as moderately severe depression; ≥ 20 as severe depression).

    Time frame: Baseline, 30 days, 90 days

  3. Anxiety symptoms

    Self-report of generalized anxiety symptoms in the prior 30 days, as measured by the Generalized Anxiety Disorder-7 (GAD-7). The GAD-7 is a 7-item instrument with each item scored between 0 and 3 where 0=not at all, and 3= nearly every day. Scores can range from 0 to 21 and are interpreted as-- scores 0-4: Minimal Anxiety, scores 5-9: Mild Anxiety, scores 10-14: Moderate Anxiety, and scores greater than 15: Severe Anxiety.

    Time frame: Baseline, 30 days, 90 days

Secondary outcomes

  1. Heavy drinking days

    The number of days during when a participant recalls heavy drinking \[having five or more drinks\], based on timeline followback, i.e., how many alcoholic drinks a participant recalls having on each specific day.

    Time frame: Baseline, 30 days, 90 days

  2. Negative alcohol consequences

    Self-report of negative alcohol consequences based on the Patient-Reported Outcomes Measurement Information System (PROMIS) Alcohol Negative Consequences Short Form. The PROMIS Alcohol Negative Consequences Short Form is a 7-item instrument with each item scored between 1 and 5 where 1=never and 5=almost always. These items are summed to calculate a raw score between 0 and 7, which is then converted to a T-score that indicates how much someone experiences negative consequences from their alcohol use relative to the United States general population. A T-score of 50 indicates that a person reported the same degree of negative alcohol consequences as the average U.S. adult, scores below 50 indicate fewer negative alcohol consequences than the average U.S. adult, and scores above 50 indicate more negative alcohol consequences than the average U.S. adult.

    Time frame: Baseline, 30 days, 90 days

  3. Intimate Personal Violence (IPV) victimization

    Measured with the Sexual and Gender Minority adaptation of the Revised Conflict Tactics Scale-Short Form, a 74-item instrument assessing specific forms of aggression (psychological, physical acts, physical injury, and sexual), as well as nonviolent conflict resolution strategies, within romantic partnerships. Each partner's use of each tactic is assessed separately (perpetration; victimization) Each item is scored from 0=Never to 6=More than 20 times. The scoring range varies by tactic, with scores of 0 representing the absence of that tactic in the past month, and higher scores indicating a greater frequency of that tactic in the past month.

    Time frame: Baseline, 30 days, 90 days

  4. Relationship satisfaction

    Measured with the Couple Satisfaction Index - 4, a four-item instrument assessing overall satisfaction in a romantic relationship. The response scales vary by item (0=Not at all, 5=Completely for one item; 0=Extremely unhappy, 6=Perfect for two items; and 0=Not at all true, 5=Completely true for one item). Scores range from 0 to 21, with higher scores indicating higher levels of relationship satisfaction and scores below 13.5 indicating marked dissatisfaction.

    Time frame: Baseline, 30 days, 90 days

  5. Component-specific user engagement

    This outcome will be assessed based on time spent on each intervention component during user testing.

    Time frame: 30 days, 90 days

  6. Participant accrual rate during the feasibility study

    Assessed from study data on the number of participants enrolled

    Time frame: 30 days, 90 days

07

Study locations

1 site
  • Boston University School of Public Health
    Boston, Massachusetts 02118, United States
    • Gabriel R Murchison, PhD MPH · Contactgrmurch@bu.edu · 617-850-2905
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06392542
Lead sponsor
Boston University
Responsible party
Sponsor
First posted
Apr 30, 2024
Start date
Sep 2027 (estimated)
Primary completion
Sep 2029 (estimated)
Completion
Sep 2029 (estimated)
Last update
Jul 28, 2026

Study contacts

Gabriel R Murchison, PhD MPH
Contact
grmurch@bu.edu
617-850-2905
Gabriel R Murchison, PhD MPH
principal investigator · Boston University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion